Vedolizumab as a successful treatment of CTLA-4–associated autoimmune enterocolitis
Details
Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: author
License: Not specified
UNIL restricted access
State: Public
Version: author
License: Not specified
Serval ID
serval:BIB_448BF89F8E32
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Vedolizumab as a successful treatment of CTLA-4–associated autoimmune enterocolitis
Journal
Journal of Allergy and Clinical Immunology
ISSN
0091-6749
Publication state
Published
Issued date
03/2017
Language
english
Create date
03/08/2020 11:46
Last modification date
04/08/2020 5:26